Biotech short sell­er lands on fed­s' watch list amid sweep­ing probe — re­port

In the face of short at­tacks, it is not un­com­mon these days for com­pa­nies to cry foul and de­fend them­selves against what they call false and mis­lead­ing state­ments. But are these short sell­ers in­volved in some­thing more ne­far­i­ous? The De­part­ment of Jus­tice is re­port­ed­ly try­ing to find out through a sweep­ing crim­i­nal in­ves­ti­ga­tion.

Fed­er­al in­ves­ti­ga­tors are scru­ti­niz­ing an un­known num­ber of hedge funds and re­search firms — along­side their trad­ing of at least sev­er­al dozen shorts — to see if any kind of de­cep­tion or ma­nip­u­la­tion was in­volved, Reuters and Bloomberg re­port­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.